Skip to main content

Closed

ELDN: Eledon Pharmaceuticals, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-64.7%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio8.44×

Eledon Pharmaceuticals, Inc.

ELDNNASDAQ Capital Market·USD·Closed

Eledon Pharmaceuticals, Inc.

ELDNNASDAQ·USD·Closed

$3.38

−0.88%

$3.38

−$0.03 (0.88%)

52W Range

62thpctl

Volume

0.47×avg

Mkt Cap

260.89MUSD

P/E

-3.9TTM

Div Yield

–ann

52W Range

62thpctl

Volume

0.47×avg

Market Cap

260.89MUSD

P/E Ratio

-3.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings